Ultragenyx Pharmaceutical RARE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's short-term investments?
- Ultragenyx Pharmaceutical (RARE) reported short-term investments of $238M in Q1 2026.
- How has Ultragenyx Pharmaceutical's short-term investments changed year-over-year?
- Ultragenyx Pharmaceutical's short-term investments decreased by 35.2% year-over-year, from $367.39M to $238M.
- What is the long-term trend for Ultragenyx Pharmaceutical's short-term investments?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's short-term investments has grown at a -11.9% compound annual growth rate (CAGR), from $488.01M to $259M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.